Klinrisk

Klinrisk finds progressive kidney disease early before kidney function is lost

Klinrisk is a business in health based in Alberta, Canada.

Profile

Klinrisk is reinventing lab medicine to improve outcomes in cardiometabolic disease. Our flagship model is the only test built for all patients with kidney disease and can help find patients at risk of progression early before kidney function is lost. We rely on routinely collected lab data and maximize the value of lab test through our machine learning algorithm. We generate a risk score for every patient with CKD, and provide clear clinical decision support which helps guide decisions about referrals, treatments and goals of care. We are commercially available in Canada, in partnership with Canada's largest lab provider - and set to launch in Europe and US (2025 and 2026) in collaboration with our global distribution partner.

Its activity falls under health; the profile below is assembled from public directory data.

Alberta, Canada is where the company is located.

The company is listed at the Plug and Play accelerated startup stage of development.

Website: www.klinrisk.com/home